Matches in Wikidata for { <http://www.wikidata.org/entity/Q63805315> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q63805315 description "clinical trial" @default.
- Q63805315 description "ensayu clínicu" @default.
- Q63805315 description "klinisch onderzoek" @default.
- Q63805315 description "клінічне випробування" @default.
- Q63805315 description "կլինիկական փորձարկում" @default.
- Q63805315 name "Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib" @default.
- Q63805315 type Item @default.
- Q63805315 label "Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib" @default.
- Q63805315 prefLabel "Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib" @default.
- Q63805315 P1050 Q63805315-0082B47F-6DC7-40D3-AE3F-98D2CF139197 @default.
- Q63805315 P1050 Q63805315-03BFCC67-AED5-4989-A955-F297D9716529 @default.
- Q63805315 P1050 Q63805315-8C2F910E-9ADC-4DB0-8185-F7B88C3D55DF @default.
- Q63805315 P1132 Q63805315-1754BF4E-FB49-4AF9-8881-271AAF854CDA @default.
- Q63805315 P1476 Q63805315-8F92F2A9-49A2-46FA-95E3-8955601C0731 @default.
- Q63805315 P2899 Q63805315-459FC881-8535-460D-B562-E4863BA70907 @default.
- Q63805315 P3098 Q63805315-960C45C3-83F0-408F-B59A-39D8B75D6CCB @default.
- Q63805315 P31 Q63805315-12C1CF55-FC4A-4614-A982-8FA9633223CD @default.
- Q63805315 P580 Q63805315-D92FD987-9712-4187-962E-A39A4F81D92D @default.
- Q63805315 P582 Q63805315-A071D06D-6E2E-455C-A10E-A8B04B59230B @default.
- Q63805315 P6099 Q63805315-8B0A6611-8A38-495A-AB84-5B5B0536D0C3 @default.
- Q63805315 P6153 Q63805315-7079E7A6-B217-4513-85B6-60FFD2DB80EA @default.
- Q63805315 P6153 Q63805315-8BBA09AB-8221-43F9-BE69-A139613CE7EB @default.
- Q63805315 P8363 Q63805315-59C10A27-B403-4841-86D6-2BDACADA1920 @default.
- Q63805315 P1050 Q3857106 @default.
- Q63805315 P1050 Q933716 @default.
- Q63805315 P1050 Q948318 @default.
- Q63805315 P1132 "+24" @default.
- Q63805315 P1476 "Phase 1b Study of PU-H71 for the Treatment of Subjects With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), Treated With Ruxolitinib" @default.
- Q63805315 P2899 "+18" @default.
- Q63805315 P3098 "NCT03935555" @default.
- Q63805315 P31 Q30612 @default.
- Q63805315 P580 "2019-05-01T00:00:00Z" @default.
- Q63805315 P582 "2020-05-15T00:00:00Z" @default.
- Q63805315 P6099 Q5452194 @default.
- Q63805315 P6153 Q174710 @default.
- Q63805315 P6153 Q7896459 @default.
- Q63805315 P8363 Q78089383 @default.